DEPLOY

Buying guide

Hugo RAS vs Mako in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

  • Hugo RAS has more verified real-world deployments (3 vs 2).
Attribute
ManufacturerMedtronicStryker
Form factorsurgicalsurgical
Maturitycommercialcommercial
Autonomy◐ not independently verified◐ not independently verified
Availabilityinternal-onlyenterpriseinternal-onlyenterprise
PriceNot announced$1,000,000-$1,500,000 (actual sale price)
Capability claims
  • Assists surgery (teleoperated-assisted, claimed)
  • Assists surgery (teleoperated-assisted, verified)
Brain
Verified deployments32United Kingdom, United States
Privacy practices
Sources on file1615

Editorial summaries

Hugo RAS

Medtronic's Hugo RAS is a modular, multi-port teleoperated robotic-assisted-surgery system and the main commercial competitor to Intuitive's da Vinci. It is CE-marked in Europe (urology and gynecology, October 2021) and US FDA-cleared for urology only (December 2025: prostatectomy, nephrectomy, cystectomy); US general-surgery and gynecology indications are planned but not yet cleared. It is teleoperated with no shipped intraoperative AI. Medtronic does not disclose a Hugo installed-base count, so DEPLOY records honest absence rather than an invented number. It is enterprise B2B equipment; there is no consumer price.

Mako

Stryker's Mako (Mako SmartRobotics) is a surgeon-guided robotic arm for orthopedic joint replacement and the large-footprint, CT-based, multi-procedure archetype of DEPLOY's orthopedic surgical sub-cohort. It pairs CT-based 3D pre-operative planning with intra-operative haptic boundary control (AccuStop physically constrains the saw or burr to the planned resection zone) and real-time optical bone tracking. Critically, it is AI-augmented but surgeon-controlled, not autonomous: the surgeon holds and guides the arm and makes every cut; the robot does not move or cut on its own, the same assistive class as Intuitive's da Vinci. Cleared procedures span partial and total knee (total knee August 2015), cementless total knee, total hip and a hip-revision feature, Mako Spine (510(k) K241517, May 2024, pedicle-screw placement) and Mako Shoulder 1.0 (510(k) K242373, November 2024, reverse shoulder arthroplasty). Sold in 45-plus countries by Stryker (NYSE: SYK). Cap-flag: Stryker frames itself in SEC filings as one of four leading global competitors, not a specific market-share percentage; aggregator share figures are not verified. As enterprise B2B surgical equipment, there is no consumer price.

Common questions

What is the difference between Hugo RAS and Mako?
Hugo RAS and Mako are both surgical robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Is Hugo RAS or Mako more autonomous?
On the DEPLOY registry, neither Hugo RAS nor Mako has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.
Which has more verified deployments, Hugo RAS or Mako?
Hugo RAS has more verified deployments (3) on the DEPLOY registry than Mako (2). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

Related comparisons

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.


Machine-readable: this page as markdown.

← Back to all consumer robots